Atara Biotherapeutics
ATRA
$0.67
Share price
3.03%
Change (1 day)
-75.64%
Change (1 year)
Categories
Earnings for Atara Biotherapeutics (ATRA)
Earnings in 2023 (TTM): -$0.28 B
According to Atara Biotherapeutics's latest financial reports the company's current earnings (TTM) are -$0.28 B. In 2022 the company made an earning of -$0.23 B an increase over its 2021 earnings that were of -$0.35 B.The earnings displayed on this page is the company's Pretax Income.
Earnings history for Atara Biotherapeutics from 2013 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2023 (TTM)  | -$0.28 B | 18.26% |
| 2022 | -$0.23 B | -32.74% |
| 2021 | -$0.35 B | 10.16% |
| 2020 | -$0.31 B | 4.52% |
| 2019 | -$0.3 B | 24.7% |
| 2018 | -$0.24 B | 95.1% |
| 2017 | -$0.13 B | 49.59% |
| 2016 | -$81.25 M | 29.06% |
| 2015 | -$62.95 M | 123.57% |
| 2014 | -$28.16 M | 226.79% |
| 2013 | -$8.62 M |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 ImmunoGen
IMGN | -$62.78 M | -76.82% | 🇺🇸 USA |
 Agenus
AGEN | -$0.16 B | -41.10% | 🇺🇸 USA |
 Affimed
AFMD | -$0.12 B | -57.58% | 🇩🇪 Germany |